Skip to content
Posted on March 31, 2023 by: eqs

开拓药业公布2022年度业绩:持续深耕差异化创新,皮科管线表现亮眼

Voice of Asia | Singapore

Singapore News & Headlines, Press Releases & Events

Posted on March 31, 2023 by: eqs

开拓药业公布2022年度业绩:持续深耕差异化创新,皮科管线表现亮眼

  • Home
  • SEAPRWire
  • EQS Newswire
  • ACN Newswire
  • JCN Newswire
  • Contact

Tag: therapeutics

  • Home
  • therapeutics
Posted on January 11, 2023 by: acn

君圣泰HTD1801治疗非酒精性脂肪性肝炎(NASH)的临床IIb 期研究(CENTRICITY研究)完成首例患者给药

       

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 11, 2023 – (亚太商讯 via SEAPRWire.com) – 君圣泰(HighTide Therapeutics Inc.)…

Continue Reading
Posted on January 5, 2023 by: acn

君圣泰完成1.07 亿美元C/C+轮融资,加速推进在研管线的全球开发、商业化和商务拓展

       

ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (亚太商讯 via SEAPRWire.com) – 君圣泰(HighTide Therapeutics Inc.)宣…

Continue Reading
Posted on August 9, 2022 by: acn

Virios Therapeutics: The ‘Virus Hypothesis’ That Stands to Change the Lives of 10M Americans

       

NEW YORK, NY, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – PCG Digital — Life may change for the better for the 10 million …

Continue Reading

Categories

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • SEAPRWire

Recent Stories

  • 开拓药业公布2022年度业绩:持续深耕差异化创新,皮科管线表现亮眼
  • 现代牙科集团公布2022年全年业绩 纯利2.2亿港元录得历史以来第二高位 构建高质量发展的综合牙科生态圈
  • Ocumension Therapeutics Announces 2022 Annual Results
  • VC Holdings Announces 2022 Annual Results
  • 嘉泓物流 (2130.HK) 公布2022全年业绩 收益按年增长4.3%至约27.9亿港元
  • 欧康维视公布2022年全年业绩
  • 汇盈控股公布2022全年业绩
  • 中国中车2022年经营业绩稳中向好
  • Honda: Notice of Change in Capital Structure of Hitachi Astemo including Capital Participation of JIC Capital
  • ESPRIT Announces Annual Results for FY 2022
  • Alltronics 2022 Profit Surges 61.6%, Driven by Robust Cost Control and Better Product Mix
  • Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
  • Baguio Green’s 2022 Net Profit* Increased by 3.2 times, Contracts On Hand Recorded a Historical High with a Surge of 67% to HK$3.6 billion
  • 华讯有效控制成本及提升产品组合 2022年溢利上升61.6%
  • 冠科美博(Apollomics Inc.)宣布完成和SPAC Maxpro合并,并在纳斯达克上市

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS Feed

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • HKBrowse
  • AccessTH
  • AseanTrend
Copyright © 2023 VOASA